Home/ Supplements/ Niacin/ ArthroSelect

ArthroSelect

product on market Capsule Moss Nutrition Safety: 96/100
96/100

This product looks safe

  • Niacinamide: 600mg is 17.1× the Tolerable Upper Intake Level (35mg)
  • 70% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains glucosamine, chondroitin, and MSM, which have moderate evidence for supporting joint health and cartilage maintenance. Boswellia serrata is included for its documented anti-inflammatory properties. Overall, the ingredient profile relies on well-studied compounds with a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacinamide: 600mg is 17.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for ArthroSelect
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
70%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

600 mg (3750% DV)
Exceeds UL by 17.1× (UL: 35 mg) 196 studies (A:5, B:63)
Market median: 1000.0mg (1115 products) 24 studies (A:0, B:9)
Market median: 1000.0mg (2 products)
Market median: 600.0mg (79 products) 25 studies (A:0, B:6)
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
Rosemary leaf extract
50 mg
Cetylated Fatty Acids
40 mg
Market median: 20.0mg (931 products) 234 studies (A:1, B:90)

Other Ingredients

Hypromellose Vegetable Stearate Silicon Dioxide Microcrystalline Cellulose Sunflower Lecithin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 4 capsules per day with meals, or as directed by your healthcare professional.

Warnings & Precautions

Warning: If you are taking medication, have a medical condition or an upcoming medical procedure, or are pregnant or nursing, consult a physician before using.

If adverse reactions occur, discontinue use & consult your healthcare practitioner.

Keep out of reach of children.

Formulation Notes

With Meriva

Supports Joint Comfort & Mobility

Does not contain gluten.

Additional Information

Store sealed in a cool, dry place.

Metadata

Product Details

UPC / SKUM003
DSLD Entry Date2022-10-24
Product TypeOther Combinations
FormCapsule
DSLD ID275495
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.